INCREASED ABUNDANCE OF ALTERNATIVELY SPLICED FORMS OF D2 DOPAMINE RECEPTOR MESSENGER-RNA AFTER DENERVATION

被引:102
作者
NEVE, KA
NEVE, RL
FIDEL, S
JANOWSKY, A
HIGGINS, GA
机构
[1] OREGON HLTH SCI UNIV, DEPT PSYCHIAT, PORTLAND, OR 97201 USA
[2] OREGON HLTH SCI UNIV, DEPT PHARMACOL, PORTLAND, OR 97201 USA
[3] NIA, GERONTOL RES CTR, BALTIMORE, MD 21224 USA
[4] UNIV CALIF IRVINE, DEPT PSYCHOBIOL, IRVINE, CA 92717 USA
关键词
D O I
10.1073/pnas.88.7.2802
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The existence of two molecular forms of D2 dopamine receptors suggests that differences in the distribution or regulation of the two forms could be exploited for the pharmacological treatment of disease. Using probes selective for each alternatively spliced variant of D2 receptor mRNA, we determined that both variants were widely distributed in rat brain and pituitary but that the ratio of the forms varied among regions. mRNA for the 444-amino acid-long variant, D2(444), was the most abundant form in pituitary and neostriatum. Intermediate levels of both D2(444) mRNA and the short form, D2(415), were detected in midbrain, and low levels of D2(444) and D2(415) mRNAs were detected in all other regions examined, including hippocampus, cerebellum, and cortex. The D2(444)/D2(415) ratio was generally lower in the regions of low expression than in pituitary and neostriatum. Dopamine-depleting lesions increased the density of D2 receptors in the denervated neostriatum by 29% without altering the affinity of the receptors for [H-3]spiperone. The proliferation of receptors appeared to be due to a lesion-induced increase of up to 120% in the abundance of both variants of mRNA in the neostriatum.
引用
收藏
页码:2802 / 2806
页数:5
相关论文
共 36 条
  • [1] ALBERT PR, 1990, J BIOL CHEM, V265, P2098
  • [2] DOPAMINE D2-RECEPTOR MESSENGER-RNA IS DIFFERENTIALLY REGULATED BY DOPAMINERGIC AGENTS IN RAT ANTERIOR AND NEUROINTERMEDIATE PITUITARY
    AUTELITANO, DJ
    SNYDER, L
    SEALFON, SC
    ROBERTS, JL
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1989, 67 (01) : 101 - 105
  • [3] A DETAILED MAPPING OF DOPAMINE D-2 RECEPTORS IN RAT CENTRAL-NERVOUS-SYSTEM BY AUTORADIOGRAPHY WITH [I-125] IODOSULPRIDE
    BOUTHENET, ML
    MARTRES, MP
    SALES, N
    SCHWARTZ, JC
    [J]. NEUROSCIENCE, 1987, 20 (01) : 117 - 155
  • [4] BOYSON SJ, 1986, J NEUROSCI, V6, P3177
  • [5] CLONING AND EXPRESSION OF A RAT D2 DOPAMINE RECEPTOR CDNA
    BUNZOW, JR
    VANTOL, HHM
    GRANDY, DK
    ALBERT, P
    SALON, J
    CHRISTIE, MJ
    MACHIDA, CA
    NEVE, KA
    CIVELLI, O
    [J]. NATURE, 1988, 336 (6201) : 783 - 787
  • [6] ANTI-SCHIZOPHRENIC DRUGS - CHRONIC TREATMENT ELEVATES DOPAMINE RECEPTOR-BINDING IN BRAIN
    BURT, DR
    CREESE, I
    SNYDER, SH
    [J]. SCIENCE, 1977, 196 (4287) : 327 - 328
  • [7] Cannon WB, 1949, SUPERSENSITIVITY DEN
  • [8] A 2ND MOLECULAR-FORM OF D2 DOPAMINE RECEPTOR IN RAT AND BOVINE CAUDATE-NUCLEUS
    CHIO, CL
    HESS, GF
    GRAHAM, RS
    HUFF, RM
    [J]. NATURE, 1990, 343 (6255) : 266 - 269
  • [9] DOPAMINE RECEPTOR-BINDING ENHANCEMENT ACCOMPANIES LESION-INDUCED BEHAVIORAL SUPERSENSITIVITY
    CREESE, I
    BURT, DR
    SNYDER, SH
    [J]. SCIENCE, 1977, 197 (4303) : 596 - 598
  • [10] THE DOPAMINE-D2 RECEPTOR - 2 MOLECULAR-FORMS GENERATED BY ALTERNATIVE SPLICING
    DALTOSO, R
    SOMMER, B
    EWERT, M
    HERB, A
    PRITCHETT, DB
    BACH, A
    SHIVERS, BD
    SEEBURG, PH
    [J]. EMBO JOURNAL, 1989, 8 (13) : 4025 - 4034